The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The erythropoietin market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 11%, as per The Business Research Company’s market report!

Read More On The Erythropoietin Market Report 2022 – https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

The Erythropoietin Market Size In 2022 And Forecast

The global erythropoietin market is expected to grow from $12.45 billion in 2021 to $13.94 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The erythropoietin (EPO) market is expected to reach $21.46 billion in 2026 at a CAGR of 11.4%.

The erythropoietin market consists of sales of erythropoietin drugs by entities (organizations, sole traders, and partnerships) that manufacture erythropoietin biosimilars.

Request for A Sample Of The Global Erythropoietin Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Rise In The Incidence Of Chronic Kidney Diseases s Driving The Growth Of The Erythropoietin Market

According to the Brazilian Journal of Nephrology’s statistics published in February 2019, kidney disease is a global public healthcare problem affecting over 750 million people across the globe. In addition to this, according to the Centers for Disease Control and Prevention’s report published on chronic kidney disease in the United States, in 2019, 15% of the adults in the USA, or 37 million people are estimated to have chronic kidney disease (CKD). CKD is more common in people aged 65 or older (38%) than in people aged 45-64 years (13%) and 18-44 years (7%). Chronic kidney diseases lead to an anaemic condition which in turn increases the demand for erythropoietin to curb the condition, thereby driving the revenues for the market.

Competitive Landscape And The Regional Analysis Of The Erythropoietin Market

Major players in the erythropoietin market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd.

Additionally, as per TBRC’s research – North America was the largest region in the erythropoietin market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.

The Erythropoietin Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the erythropoietin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the erythropoietin market.

Erythropoietin Market Segmentation By The Business Research Company

1) By Product: Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa, Others

2) By Application: Cancer, Hematology, Renal Diseases, Neurology, Others

3) By Drug Class: Biologics, Biosimilar

Here Are Some Reports Related To The Erythropoietin Market –

Biosimilar Therapeutic Peptides Global Market Report 2022

Pharmaceutical Drugs Global Market Report 2022

Generic Pharmaceuticals Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: